Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)
China · Delayed Price · Currency is CNY 5.47
+0.25 (4.79%)
Jul 29, 2026, 3:04 PM CST
SHE:002099 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 842.81 | 1,379 | 1,517 | 1,421 | 1,491 | 1,828 |
Trading Asset Securities | 15.51 | 14.38 | 45.03 | - | - | 9.48 |
Cash & Short-Term Investments | 858.32 | 1,394 | 1,562 | 1,421 | 1,491 | 1,837 |
Cash Growth | -51.29% | -10.78% | 9.96% | -4.71% | -18.86% | -6.72% |
Accounts Receivable | 502.85 | 463.99 | 460.09 | 445.14 | 541.38 | 521.07 |
Other Receivables | 5.47 | 3.59 | 7.01 | 10.3 | 42.9 | 56.48 |
Receivables | 508.32 | 467.57 | 467.09 | 455.44 | 584.28 | 577.54 |
Inventory | 984.11 | 901.91 | 799.71 | 702.27 | 1,102 | 907.97 |
Other Current Assets | 79.11 | 69.41 | 61.9 | 47.45 | 68.15 | 114 |
Total Current Assets | 2,430 | 2,833 | 2,891 | 2,626 | 3,246 | 3,437 |
Property, Plant & Equipment | 2,809 | 2,872 | 2,961 | 3,029 | 3,098 | 2,981 |
Long-Term Investments | 736.8 | 227.13 | 174.84 | 671.67 | 720.88 | 259.42 |
Goodwill | 394.84 | 394.84 | 394.84 | 603.31 | 711.01 | 757.74 |
Other Intangible Assets | 499.99 | 503.41 | 520.43 | 520.8 | 555.76 | 490.13 |
Long-Term Deferred Tax Assets | 50.65 | 42.95 | 42.56 | 41.57 | 52.34 | 52.18 |
Long-Term Deferred Charges | 0.85 | 1.23 | 2.8 | 4.04 | 2.06 | 2.52 |
Other Long-Term Assets | 124.34 | 459.32 | 469.15 | 23.65 | 7.81 | 39.82 |
Total Assets | 7,047 | 7,333 | 7,456 | 7,520 | 8,393 | 8,020 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 809.39 | 783.71 | 862.1 | 603.34 | 995.04 | 1,029 |
Accrued Expenses | 34.19 | 81.9 | 82.87 | 81.61 | 81.72 | 88.24 |
Short-Term Debt | 1,091 | 1,284 | 1,222 | 1,030 | 833.81 | 571.93 |
Current Portion of Long-Term Debt | - | - | - | 10.01 | 2 | - |
Current Portion of Leases | 4.93 | 4.93 | 5.26 | 4.46 | 3.84 | 3.82 |
Current Income Taxes Payable | 21.15 | 3.42 | 9.4 | 5.06 | 3.42 | 9.52 |
Current Unearned Revenue | 15.62 | 17.99 | 12.67 | 10.13 | 8.16 | 9.7 |
Other Current Liabilities | 46.24 | 39.95 | 34.12 | 62.03 | 42.69 | 20.72 |
Total Current Liabilities | 2,023 | 2,216 | 2,228 | 1,807 | 1,971 | 1,733 |
Long-Term Debt | - | - | - | - | 148.14 | - |
Long-Term Leases | 0.42 | 0.55 | 6.62 | 10.21 | 14.01 | 17.82 |
Long-Term Unearned Revenue | 45.89 | 47.1 | 54.4 | 57.31 | 54.44 | 53.45 |
Long-Term Deferred Tax Liabilities | 44.4 | 37.54 | 33.57 | 41.34 | 99.58 | 101.03 |
Other Long-Term Liabilities | 1.33 | 1.33 | 1.33 | 2.68 | 1.33 | 1.33 |
Total Liabilities | 2,115 | 2,302 | 2,324 | 1,918 | 2,288 | 1,906 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,619 | 1,619 | 1,619 | 1,619 | 1,619 | 1,619 |
Additional Paid-In Capital | 2,920 | 2,920 | 2,917 | 2,906 | 2,906 | 2,844 |
Retained Earnings | 705.96 | 679.51 | 749.14 | 1,079 | 1,580 | 1,654 |
Treasury Stock | -302.57 | -177.51 | -151.42 | - | - | - |
Comprehensive Income & Other | -1.29 | -1.29 | 5.78 | 1.95 | 2.59 | -1.64 |
Total Common Equity | 4,941 | 5,040 | 5,139 | 5,606 | 6,108 | 6,115 |
Minority Interest | -8.95 | -8.81 | -7.24 | -4.63 | -3.06 | -1.38 |
Shareholders' Equity | 4,932 | 5,031 | 5,132 | 5,602 | 6,105 | 6,114 |
Total Liabilities & Equity | 7,047 | 7,333 | 7,456 | 7,520 | 8,393 | 8,020 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,096 | 1,289 | 1,234 | 1,055 | 1,002 | 593.57 |
Net Cash (Debt) | -238.06 | 104.37 | 328.28 | 365.71 | 489.02 | 1,244 |
Net Cash Growth | - | -68.21% | -10.23% | -25.22% | -60.69% | -19.17% |
Net Cash Per Share | -0.15 | 0.07 | 0.21 | 0.23 | 0.28 | 0.78 |
Filing Date Shares Outstanding | 1,565 | 1,583 | 1,587 | 1,619 | 1,619 | 1,619 |
Total Common Shares Outstanding | 1,565 | 1,583 | 1,587 | 1,619 | 1,619 | 1,619 |
Working Capital | 407.3 | 616.84 | 662.46 | 818.91 | 1,275 | 1,704 |
Book Value Per Share | 3.16 | 3.18 | 3.24 | 3.46 | 3.77 | 3.78 |
Tangible Book Value | 4,046 | 4,141 | 4,224 | 4,482 | 4,841 | 4,867 |
Tangible Book Value Per Share | 2.59 | 2.62 | 2.66 | 2.77 | 2.99 | 3.01 |
Buildings | - | 1,918 | 1,692 | 1,699 | 1,514 | 1,304 |
Machinery | - | 3,292 | 3,168 | 3,146 | 3,025 | 2,610 |
Construction In Progress | - | 414.64 | 564.58 | 372.91 | 449.12 | 670.81 |